Abstract

Different mutations of the OTOF gene, encoding for otoferlin protein expressed in the cochlear inner hair cells, induces a form of deafness that is the major cause of nonsyndromic recessive auditory neuropathy spectrum disorder in humans. We report the generation of the first large animal model of OTOF mutations using the CRISPR system associated with different Cas9 components (mRNA or protein) assisted by single strand oligodeoxynucleotides (ssODN) to induce homology-directed repair (HDR). Zygote microinjection was performed with two sgRNA targeting exon 5 and 6 associated to Cas9 mRNA or protein (RNP) at different concentrations in a mix with an ssODN template targeting HDR in exon 5 containing two STOP sequences. A total of 73 lambs were born, 13 showing indel mutations (17.8%), 8 of which (61.5%) had knock-in mutations by HDR. Higher concentrations of Cas9-RNP induced targeted mutations more effectively, but negatively affected embryo survival and pregnancy rate. This study reports by the first time the generation of OTOF disrupted sheep, which may allow better understanding and development of new therapies for human deafness related to genetic disorders. These results support the use of CRISPR/Cas system assisted by ssODN as an effective tool for gene editing in livestock.

Details

Title
Otoferlin gene editing in sheep via CRISPR-assisted ssODN-mediated Homology Directed Repair
Author
Menchaca, A 1   VIAFID ORCID Logo  ; dos Santos-Neto P C 1 ; Souza-Neves, M 1 ; Cuadro, F 1 ; Mulet, A P 2 ; Tesson, L 3 ; Chenouard, V 3 ; Guiffès, A 3 ; Heslan, J M 4 ; Gantier, M 4 ; Anegón, I 5 ; Crispo, M 2 

 Instituto de Reproducción Animal Uruguay, Fundación IRAUy, Montevideo, Uruguay 
 Unidad de Animales Transgénicos y de Experimentación (UATE), Institut Pasteur de Montevideo, Montevideo, Uruguay (GRID:grid.418532.9) 
 Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, Nantes, France (GRID:grid.462425.3) (ISNI:0000 0004 0449 1513); Transgenesis Rat ImmunoPhenomic facility (TRIP), Nantes, France (GRID:grid.462425.3) 
 Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, Nantes, France (GRID:grid.462425.3) (ISNI:0000 0004 0449 1513); GenoCellEdit facility, Nantes, France (GRID:grid.462425.3) 
 Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, Nantes, France (GRID:grid.462425.3) (ISNI:0000 0004 0449 1513); Transgenesis Rat ImmunoPhenomic facility (TRIP), Nantes, France (GRID:grid.462425.3); GenoCellEdit facility, Nantes, France (GRID:grid.462425.3) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2387248379
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.